|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:awarded
|
gptkb:India_Pharma_Innovation_of_the_Year_2021
|
|
gptkbp:country
|
gptkb:India
|
|
gptkbp:developedBy
|
gptkb:ZyCoV-D
|
|
gptkbp:focusArea
|
gptkb:diabetes
animal health
infectious diseases
oncology
biosimilars
vaccines
women's health
gastroenterology
pain management
cardiovascular
respiratory
active pharmaceutical ingredients
injectables
oral liquids
oral solids
topical products
transdermal products
|
|
gptkbp:foundedBy
|
gptkb:Ramanbhai_Patel
|
|
gptkbp:foundedYear
|
1952
|
|
gptkbp:hasResearchCenter
|
gptkb:Zydus_Research_Centre,_Ahmedabad
|
|
gptkbp:headquartersLocation
|
gptkb:Ahmedabad
|
|
gptkbp:industry
|
pharmaceuticals
|
|
gptkbp:keyPerson
|
gptkb:Pankaj_Patel
Sharvil Patel
|
|
gptkbp:listedOn
|
BSE: 532321
NSE: CADILAHC
|
|
gptkbp:market
|
global
|
|
gptkbp:notableProduct
|
gptkb:Lipaglyn
gptkb:Remdac
gptkb:Saroglitazar
gptkb:Udenafil
gptkb:ZyCoV-D
|
|
gptkbp:numberOfEmployees
|
23000
|
|
gptkbp:parentCompany
|
gptkb:Cadila_Healthcare
|
|
gptkbp:product
|
biosimilars
generic drugs
vaccines
OTC products
|
|
gptkbp:renamed
|
gptkb:Zydus_Lifesciences
|
|
gptkbp:stockExchange
|
gptkb:NSE
BSE
|
|
gptkbp:subsidiary
|
gptkb:German_Remedies
gptkb:Liva_Pharmaceuticals
gptkb:Zydus_Animal_Health
gptkb:Zydus_Wellness
|
|
gptkbp:website
|
https://www.zyduscadila.com/
|
|
gptkbp:ZyCoV-D
|
COVID-19 DNA vaccine
|
|
gptkbp:bfsParent
|
gptkb:Pankaj_R._Patel
|
|
gptkbp:bfsLayer
|
5
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Zydus Cadila
|